Arcutis Biotherapeutics, Inc.

Biotechnology • Healthcare • Westlake Village, CA, United States • ARQT (NMS)

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Arcutis Biotherapeutics stock today: ARQT ends 2025 up 3.4% as traders eye FDA, earnings dates - ts2.tech

ts2.tech • Jan 2

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Rating Lowered by Zacks Research - MarketBeat

MarketBeat • Dec 31

What Makes Arcutis Biotherapeutics, Inc. (ARQT) a Strong Momentum Stock: Buy Now? - Nasdaq

Nasdaq • Dec 10

Assessing Arcutis Biotherapeutics (ARQT) Valuation After Its Strong 1-Year Share Price Surge - Yahoo Finance

Yahoo Finance • Dec 3

Why Shares in Arcutis Biotherapeutics Surged Again This Week - The Motley Fool

The Motley Fool • Nov 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Arcutis Biotherapeutics, Inc. had layoffs?

No layoff events have been recorded for Arcutis Biotherapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Arcutis Biotherapeutics, Inc. have?

Arcutis Biotherapeutics, Inc. has approximately 342 employees.

What industry is Arcutis Biotherapeutics, Inc. in?

Arcutis Biotherapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Arcutis Biotherapeutics, Inc. a publicly traded company?

Yes, Arcutis Biotherapeutics, Inc. is publicly traded under the ticker symbol ARQT on the NMS. The company has a market capitalization of approximately $3.59 billion.

Where is Arcutis Biotherapeutics, Inc. headquartered?

Arcutis Biotherapeutics, Inc. is headquartered in Westlake Village, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.